Literature DB >> 15096461

Asymmetrical dimethylarginine: the Uber marker?

John P Cooke1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15096461     DOI： 10.1161/01.CIR.0000126823.07732.D5

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  81 in total

1.  Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigm.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

Review 2.  Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor.

Authors:  John P Cooke
Journal:  Life Sci       Date:  2007-02-17       Impact factor: 5.037

3.  Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.

Authors:  Eva Schepers; Daniela V Barreto; Sophie Liabeuf; Griet Glorieux; Sunny Eloot; Fellype C Barreto; Ziad Massy; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 8.237

4.  Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.

Authors:  Johannes Jacobi; Renke Maas; Arturo J Cardounel; Michaela Arend; Arthur J Pope; Nada Cordasic; Juliane Heusinger-Ribeiro; Dorothee Atzler; Joachim Strobel; Edzard Schwedhelm; Rainer H Böger; Karl F Hilgers
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

5.  DDAH says NO to ADMA.

Authors:  John P Cooke; Yohannes T Ghebremariam
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

6.  Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment.

Authors:  Balazs Nemeth; Istvan Kiss; Timea Jencsik; Ivan Peter; Zita Kreska; Tamas Koszegi; Attila Miseta; Peter Kustan; Imre Boncz; Andrea Laczo; Zeno Ajtay
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

7.  Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1.

Authors:  Ruslan Rafikov; Olga Rafikova; Saurabh Aggarwal; Christine Gross; Xutong Sun; Julin Desai; David Fulton; Stephen M Black
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.

Authors:  Raf Brouns; Bart Marescau; Ilse Possemiers; Rishi Sheorajpanday; Peter P De Deyn
Journal:  Neurochem Res       Date:  2009-03-19       Impact factor: 3.996

9.  Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

Authors:  Wolfgang Lieb; Ralf A Benndorf; Emelia J Benjamin; Lisa M Sullivan; Renke Maas; Vanessa Xanthakis; Edzard Schwedhelm; Jayashri Aragam; Friedrich Schulze; Rainer H Böger; Ramachandran S Vasan
Journal:  Atherosclerosis       Date:  2008-08-28       Impact factor: 5.162

10.  Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals.

Authors:  Rushi V Parikh; Rebecca Scherzer; Carl Grunfeld; Elaine M Nitta; Anna Leone; Jeffrey N Martin; Steven G Deeks; Peter Ganz; Priscilla Y Hsue
Journal:  Atherosclerosis       Date:  2013-04-30       Impact factor: 5.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.